Literature DB >> 28939767

Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.

Sathya Challasivakanaka1, Juan Zhen2, Margaret E Smith1, Maarten E A Reith2,3, James D Foster1, Roxanne A Vaughan4.   

Abstract

The dopamine transporter (DAT) controls the spatial and temporal dynamics of dopamine neurotransmission through reuptake of extracellular transmitter and is a target for addictive compounds such as cocaine, amphetamine (AMPH), and methamphetamine (METH). Reuptake is regulated by kinase pathways and drug exposure, allowing for fine-tuning of clearance in response to specific conditions, and here we examine the impact of transporter ligands on DAT residue Thr-53, a proline-directed phosphorylation site previously implicated in AMPH-stimulated efflux mechanisms. Our findings show that Thr-53 phosphorylation is stimulated in a transporter-dependent manner by AMPH and METH in model cells and rat striatal synaptosomes, and in striatum of rats given subcutaneous injection of METH. Rotating disc electrode voltammetry revealed that initial rates of uptake and AMPH-induced efflux were elevated in phosphorylation-null T53A DAT relative to WT and charge-substituted T53D DATs, consistent with functions related to charge or polarity. These effects occurred without alterations of surface transporter levels, and mutants also showed reduced cocaine analog binding affinity that was not rescued by Zn2+ Together these findings support a role for Thr-53 phosphorylation in regulation of transporter kinetic properties that could impact DAT responses to amphetamines and cocaine.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  dopamine transporter; extracellular-signal-regulated kinase (ERK); methamphetamine; mitogen-activated protein kinase (MAPK); phospho-specific antibody; phosphorylation; proline directed phosphorylation; protein kinase C (PKC); rotating disc electrode voltammetry

Mesh:

Substances:

Year:  2017        PMID: 28939767      PMCID: PMC5704487          DOI: 10.1074/jbc.M117.787002

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Getting in the ring: proline-directed substrate specificity in the cell cycle proteins Cdc14 and CDK2-cyclinA3.

Authors:  Christopher H Gray; David Barford
Journal:  Cell Cycle       Date:  2003 Nov-Dec       Impact factor: 4.534

2.  Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum.

Authors:  X Shi; J F McGinty
Journal:  Neuroscience       Date:  2006-02-03       Impact factor: 3.590

Review 3.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.

Authors:  Kun Ping Lu; Xiao Zhen Zhou
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

4.  Molecular cloning and functional expression of the mouse dopamine transporter.

Authors:  M Brüss; A Wieland; H Bönisch
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

5.  Dopamine Transporter Amino and Carboxyl Termini Synergistically Contribute to Substrate and Inhibitor Affinities.

Authors:  Carolyn G Sweeney; Bradford P Tremblay; Thomas Stockner; Harald H Sitte; Haley E Melikian
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

6.  Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics.

Authors:  Amy E Moritz; Danielle E Rastedt; Daniel J Stanislowski; Madhur Shetty; Margaret A Smith; Roxanne A Vaughan; James D Foster
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

7.  Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

Authors:  James D Foster; Benchaporn Pananusorn; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

8.  X-ray structures of LeuT in substrate-free outward-open and apo inward-open states.

Authors:  Harini Krishnamurthy; Eric Gouaux
Journal:  Nature       Date:  2012-01-09       Impact factor: 49.962

9.  Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Authors:  Yvette Dehnes; Jufang Shan; Thijs Beuming; Lei Shi; Harel Weinstein; Jonathan A Javitch
Journal:  Neurochem Int       Date:  2014-02-24       Impact factor: 3.921

10.  Amphetamine increases phosphorylation of MAPK/ERK at synaptic sites in the rat striatum and medial prefrontal cortex.

Authors:  Li-Min Mao; James M Reusch; Eugene E Fibuch; Zhenguo Liu; John Q Wang
Journal:  Brain Res       Date:  2012-11-29       Impact factor: 3.252

View more
  8 in total

1.  Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559.

Authors:  Raajaram Gowrishankar; Paul J Gresch; Gwynne L Davis; Rania M Katamish; Justin R Riele; Adele M Stewart; Roxanne A Vaughan; Maureen K Hahn; Randy D Blakely
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

2.  Identification of the benztropine analog [125I]GA II 34 binding site on the human dopamine transporter.

Authors:  Michael J Tomlinson; Danielle Krout; Akula Bala Pramod; John R Lever; Amy Hauck Newman; L Keith Henry; Roxanne A Vaughan
Journal:  Neurochem Int       Date:  2018-08-17       Impact factor: 3.921

3.  Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.

Authors:  Zachary D Brodnik; Wei Xu; Aashita Batra; Stacia I Lewandowski; Christina M Ruiz; Ole V Mortensen; Sandhya Kortagere; Stephen V Mahler; Rodrigo A España
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

4.  Dopamine Evokes a Trace Amine Receptor-dependent Inward Current that is Regulated by AMP Kinase in Substantia Nigra Dopamine Neurons.

Authors:  Wei Yang; Adam C Munhall; Steven W Johnson
Journal:  Neuroscience       Date:  2019-12-26       Impact factor: 3.590

5.  Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.

Authors:  I P Alonso; J A Pino; S Kortagere; G E Torres; R A España
Journal:  Neuropsychopharmacology       Date:  2020-10-08       Impact factor: 7.853

6.  Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.

Authors:  Florence Allain; Benoît Delignat-Lavaud; Marie-Pierre Beaudoin; Vincent Jacquemet; Terry E Robinson; Louis-Eric Trudeau; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2020-07-18       Impact factor: 7.853

7.  Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.

Authors:  Ulrika H Julku; Maria Jäntti; Reinis Svarcbahs; Timo T Myöhänen
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

8.  Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.

Authors:  Durairaj Ragu Varman; Mark A Subler; Jolene J Windle; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Behav Brain Res       Date:  2021-03-29       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.